Bleomycin-induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting form
- PMID: 10524560
- DOI: 10.1007/s100670050131
Bleomycin-induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting form
Abstract
We report a case of bleomycin-induced scleroderma in a 35-year-old woman treated with chemotherapy for Hodgkin's disease. Approximately 6 months after the first chemotherapy cycle, the patient developed skin sclerosis in both arms. The lesion showed no signs of spontaneous clinical amelioration and treatment with steroids was unsuccessful. A partial remission of the skin sclerosis was instead obtained by the administration of D-penicillamine. A family history revealed other cases of autoimmune diseases and HLA typing showed the presence of antigens associated with scleroderma. The association between bleomycin therapy and scleroderma is discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials